National Health Investors Announces CFO Retirement and Appoints Experienced REIT Veteran Todd Siefert as Successor

summarizeSummary

National Health Investors announced the retirement of its CFO, John L. Spaid, effective July 1, 2026, and the appointment of Todd Siefert, an executive with extensive REIT and capital markets experience, as his successor.

check_boxKey Events

• CFO Retirement Announced

  John L. Spaid, Executive Vice President of Finance, Chief Financial Officer, and Treasurer, will retire effective July 1, 2026. The company stated his retirement is not due to any disagreement.

• New CFO Appointed

  Todd Siefert, 52, was appointed Executive Vice President Corporate Finance, effective June 1, 2026, and will assume the CFO role upon Mr. Spaid's retirement.

• Successor's Extensive Experience

  Mr. Siefert brings over 25 years of experience in corporate finance, capital markets, treasury management, and investor relations, with deep expertise in publicly traded REITs, including a prior role at Ryman Hospitality Properties (NYSE:RHP).

• Compensation Package Detailed

  Mr. Siefert's compensation includes an initial annual base salary of $500,000, eligibility for a prorated 2026 annual performance-based cash incentive up to $490,000, a prorated 2026 annual equity award target of $437,500, a one-time signing bonus of $100,000, and a one-time grant of an option to purchase 50,000 shares.

auto_awesomeAnalysis

National Health Investors announced a planned and amicable CFO transition, with John L. Spaid retiring and Todd Siefert appointed as his successor. Siefert brings over 25 years of corporate finance, capital markets, and REIT experience, including a significant role at Ryman Hospitality Properties, a larger publicly traded REIT. This leadership change is particularly important as it follows closely on the heels of the company's recent major asset disposition, requiring strong financial stewardship and strategic capital allocation. Siefert's expertise in capital markets and balance sheet restructuring suggests a focus on optimizing the company's financial structure post-sale.